This review builds on these studies for the treatment of bacterial infections and describes the therapeutic potential of AMP‐based therapies, which include natural AMPs, AMP optimization strategies, AMP and biomaterial delivery systems, and AMP and nanoparticle noncovalent conjugation approaches. The gene discussed is ADSL; the disease is bacterial infectious disease.